Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Including ovarian morphology in diagnosis increases PCOS prevalence estimates, highlighting the need for standardized criteria.

Stem cell therapies may help improve symptoms and quality of life for people with epidermolysis bullosa.

Alopecia treatments improve life quality but side effects can lessen this benefit; better use of quality of life measures is needed.

Hyaluronic acid hydrates and benefits skin and hair safely.

Machine learning and single-cell analysis improve understanding and treatment of wound healing.

Effective delivery systems are crucial for siRNA hair loss treatments to work better.

Cellulose-based skin dressings show promise for wound healing but need more research and clinical trials.

Hair steroid profiling is a feasible, non-invasive alternative to serum analysis for assessing hormone levels and metabolism.

PRP shows promise for hair growth, but more research and standardized protocols are needed.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

A mutation in the KRT74 gene causes woolly hair by affecting hair texture.

Accurate clinical, histological, and genetic methods are key for understanding and treating hair disorders.

Human hair follicle stem cells can become endothelial cells with certain growth factors, useful for vascular treatments.

An automated system can predict death risk in thin melanoma by analyzing immune cells.

A mutation in the KRT74 gene causes woolly hair by affecting hair texture.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

The document recommends using both clinical evaluation and various measurement methods to assess skin greasiness, considering factors like temperature and hormones.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

Medical practitioners need to understand basic statistics to properly evaluate clinical trials and avoid unethical designs.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

Hair follicle stem cells are promising for wound healing but require more research for safe clinical use.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Two-photon microscopy improves skin imaging but faces safety and cost challenges for clinical use.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.